Skip to content

Monster Beverage

US · MNST #266 by market cap Listed 1970
42.88 -0.37 -0.86%
Live - 5344 symbols - heartbeat 429s ago · 2026-10-08 08:20
Pre-market 43.04 +0.37%
After-hours 42.58 -0.69%
Overnight 42.85 -0.07%
Market cap
84.00B
P/B
8.97
EPS
0.97
Reader sentiment Are you bullish or bearish on MNST?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good
  • Altman Z-Score is 32.46, above the 3.0 "safe zone" threshold.
  • Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +10.70% YoY

Margins

Gross margin
55.85%
Operating margin
29.17%
Net margin
22.97%

Key ratios & quality

PEG uses trailing P/E against the 3-year net income growth rate (16.94%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item 2018 2019 2020 2021 2022 2023 2024 2025
Revenue 3.81B4.20B4.60B5.54B6.31B7.14B7.49B8.29B
Gross profit 2.30B2.52B2.72B3.11B3.17B3.79B4.05B4.63B
Selling & admin expenses ----------------
Research & development ----------------
Operating profit 1.28B1.40B1.63B1.80B1.58B1.95B1.93B2.42B
Pretax profit 1.29B1.42B1.63B1.80B1.57B2.07B1.99B2.48B
Tax 300.27M308.13M216.56M423.94M380.34M437.49M480.41M577.10M
Net profit 993.00M1.11B1.41B1.38B1.19B1.63B1.51B1.91B
Basic EPS 01111111
Diluted EPS 0.440.510.660.650.560.770.750.97

Balance sheet

Line item 2018 2019 2020 2021 2022 2023 2024 2025
Total current assets 1.80B2.32B3.14B4.68B4.76B5.59B3.64B5.36B
Cash & ST investments 958.16M1.33B2.06B3.08B2.67B3.25B1.53B2.77B
Inventory 277.71M360.73M333.09M593.36M935.63M971.41M737.11M799.62M
Total assets 4.53B5.15B6.20B7.80B8.29B9.69B7.72B9.99B
Total current liabilities 601.15M661.10M749.99M965.08M1.00B1.16B1.10B1.45B
Short-term debt ----------------
Long-term debt ------------373.95M--
Total liabilities 915,990,000.00979,071,000.001,041,856,000.001,237,833,000.001,268,064,000.001,457,778,000.001,761,371,000.001,734,837,000.00
Total equity 3.61B4.17B5.16B6.57B7.03B8.23B5.96B8.25B
Retained earnings 3.91B5.02B6.43B7.81B9.00B5.94B7.45B9.35B

Cash flow

Line item 2018 2019 2020 2021 2022 2023 2024 2025
Operating cash flow 1.16B1.11B1.36B1.16B887.70M1.72B1.93B2.10B
Depreciation & amortization 56.98M60.73M57.03M50.16M61.24M68.90M80.43M114.44M
Free cash flow 1.09B1.00B1.30B1.10B675.55M1.48B1.62B1.94B
Dividends paid ----------------
Stock buybacks / issuance -1.31B-614.94M-522.98M31.89M-707.01M-528.69M-3.69B60.92M
Ending cash balance 637.51M797.96M1.18B1.33B1.31B2.30B1.53B2.09B

Returns & efficiency

Line item 2018 2019 2020 2021 2022 2023 2024 2025
ROE % 26.4628.4730.2123.4917.5321.3821.2726.81
ROA % 21.3122.9024.8319.6714.8018.1417.3421.52
ROIC % 26.4628.4730.2123.4917.5321.3820.2126.81
5-year avg ROE % 24.5022.4925.0726.2725.2324.2222.7822.10
EBIT margin % 33.7233.4035.5132.4425.1127.3625.7629.17
FCF / sales % 28.5523.8928.2019.8210.7020.7721.6523.40
Current ratio 3.003.504.194.854.764.813.323.70
Quick ratio 2.402.833.644.123.683.832.513.03
Debt / assets ------------4.84--
LT debt / equity ------------6.28--
Interest coverage ----------------
Revenue CAGR (3Y) % 11.8311.2710.9313.3314.5315.8010.589.54
Net income CAGR (3Y) % 22.0115.8419.7611.532.464.983.0916.94
FCF CAGR (3Y) % 31.3018.9613.180.35-12.354.5713.8842.16

✦ Quant Revenue Concentration how this is computed

Single-engine
  • Monster Energy® Drinks is the largest reported line at 92.85% of revenue, across 4 reported segments.
  • The next-largest line, Strategic Brands, is a distant second at 5.66% - a sharp slowdown here would have little to offset it.

Revenue breakdown most recent period

Business

Monster Energy® Drinks92.85%
Strategic Brands5.66%
Alcohol Brands1.27%
Other0.21%

Quote time 2026-10-08 08:20:41 · For reference only, not investment advice and not tailored to your situation.